Smoking drug may pose psychiatric risks

Share this content:
The Food and Drug Administration announced that the connection between Pfizer's anti-smoking drug Chantix and serious psychiatric problems is "increasingly likely." The agency said it received reports of more than three dozen suicides and more than 400 instances of suicidal behavior in connection with the medication.

Next Article in Products